Home » Topics » Regulatory » Patents

Patents
RSS

4SC Discovery patents KCNA3 channel blockers

Sep. 30, 2016

Merck & Co. develops IRAK-4 inhibitors

Sep. 29, 2016

French scientists describe FGFR3 inhibitors

Sep. 29, 2016

Pharmakea discloses ENPP2 inhibitors

Sep. 29, 2016

Vectus Biosystems patents vasodilating agents

Sep. 29, 2016

MFMER reports NADH-ubiquinone oxidoreductase inhibitors

Sep. 28, 2016

Shuttle Pharmaceuticals presents HDAC inhibitors and erine-protein kinase ATM activators

Sep. 28, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

Genentech and Hoffmann-La Roche describe DLK inhibitors

Sep. 28, 2016

Hoffmann-La Roche discloses TLR8 agonists

Sep. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...